Ambrilia Biopharma Inc., a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today that it will be hosting a conference call on Wednesday, May 10th at 4:30 p.m. ET, to discuss its first quarter 2006 financial results and provide an update on its product pipeline milestones.
